Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith A Aberg

Showing results (131-140 of 212) with videos related to

Pageof 22
Sort By:
AIDS (London, England)|September 16, 2024
Proteinuria and albuminuria among a global primary cardiovascular disease prevention cohort of people with HIVEdgar T Overton, Amy Kantor, Kathleen V Fitch, et al.
Open Forum Infectious Diseases|December 10, 2021
Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency VirusEmma M Kileel, Janet Lo, Carlos Malvestutto, et al.
Annals of Internal Medicine|September 11, 2003
Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trialDonald I Abrams, Joan F Hilton, Roslyn J Leiser, et al.
JAMA|July 20, 2010
Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panelMelanie A Thompson, Judith A Aberg, Pedro Cahn, et al.
The Journal of Infectious Diseases|May 10, 2022
Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic SubstudyMárton Kolossváry, Chris deFilippi, Michael T Lu, et al.
Transfusion|October 30, 2020
Transfusion reactions associated with COVID-19 convalescent plasma therapy for SARS-CoV-2Freddy T Nguyen, Tayler van den Akker, Kimberly Lally, et al.
Addiction Science & Clinical Practice|May 16, 2022
Toward Safer Opioid Prescribing in HIV care (TOWER): a mixed-methods, cluster-randomized trialGabriela Cedillo, Mary Catherine George, Richa Deshpande, et al.
The Journal of Infectious Diseases|April 21, 2020
Differential Plasma Protein Regulation and Statin Effects in Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Patients Utilizing a Proteomics ApproachChris deFilippi, Mabel Toribio, Lai Ping Wong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2009
Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211Athe M N Tsibris, Roger Paredes, Amy Chadburn, et al.
Ebiomedicine|March 26, 2023
Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIVMárton Kolossváry, Chris deFilippi, Sara McCallum, et al.
Pageof 22

Showing results (131-140 of 212) with videos related to

Sort By:
Pageof 22
AIDS (London, England)|September 16, 2024
Proteinuria and albuminuria among a global primary cardiovascular disease prevention cohort of people with HIVEdgar T Overton, Amy Kantor, Kathleen V Fitch, et al.
Open Forum Infectious Diseases|December 10, 2021
Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency VirusEmma M Kileel, Janet Lo, Carlos Malvestutto, et al.
Annals of Internal Medicine|September 11, 2003
Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trialDonald I Abrams, Joan F Hilton, Roslyn J Leiser, et al.
JAMA|July 20, 2010
Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panelMelanie A Thompson, Judith A Aberg, Pedro Cahn, et al.
The Journal of Infectious Diseases|May 10, 2022
Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic SubstudyMárton Kolossváry, Chris deFilippi, Michael T Lu, et al.
Transfusion|October 30, 2020
Transfusion reactions associated with COVID-19 convalescent plasma therapy for SARS-CoV-2Freddy T Nguyen, Tayler van den Akker, Kimberly Lally, et al.
Addiction Science & Clinical Practice|May 16, 2022
Toward Safer Opioid Prescribing in HIV care (TOWER): a mixed-methods, cluster-randomized trialGabriela Cedillo, Mary Catherine George, Richa Deshpande, et al.
The Journal of Infectious Diseases|April 21, 2020
Differential Plasma Protein Regulation and Statin Effects in Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Patients Utilizing a Proteomics ApproachChris deFilippi, Mabel Toribio, Lai Ping Wong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2009
Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211Athe M N Tsibris, Roger Paredes, Amy Chadburn, et al.
Ebiomedicine|March 26, 2023
Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIVMárton Kolossváry, Chris deFilippi, Sara McCallum, et al.
Pageof 22